Corium International Company
Corium International engages in the development of advanced transdermal drug delivery technologies and products.
Funding Status:
M&A
Headquarters:
Menlo Park, California, United States
Founded Date:
1995
Investor Type:
N/A
Investment Stage:
N/A
Technology:
Immunotherapy
Employee Number:
501-1000
Number Of Exists:
N/A
Estimated Revenue:
$10M to $50M
Industry:
PharmTech